(90)Y ibritumomab tiuxetan (Zevalin) combined with BEAM (Z -BEAM) conditioning regimen plus autologous stem cell transplantation in relapsed or refractory low-grade CD20-positive B-cell lymphoma. A GELA phase II prospective study (Q56986140)
Jump to navigation
Jump to search
scientific article published on 09 April 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | (90)Y ibritumomab tiuxetan (Zevalin) combined with BEAM (Z -BEAM) conditioning regimen plus autologous stem cell transplantation in relapsed or refractory low-grade CD20-positive B-cell lymphoma. A GELA phase II prospective study |
scientific article published on 09 April 2011 |
Statements
(90)Y ibritumomab tiuxetan (Zevalin) combined with BEAM (Z -BEAM) conditioning regimen plus autologous stem cell transplantation in relapsed or refractory low-grade CD20-positive B-cell lymphoma. A GELA phase II prospective study (English)
Didier Decaudin
Hervé Tilly
Vincent Ribrag
Hervé Ghesquières
Krimo Bouabdallah
Franck Morschhauser
Bertrand Coiffier
Steven Le Gouill
Serge Bologna
Richard Delarue
Anne Huynh
André Bosly
Josette Brière
Christian Gisselbrecht